Trials / Unknown
UnknownNCT01605110
Effects of Hyperbaric Oxygen Therapy on Surgical Wound Healing
Effects of HBOT for Edema/Ecchymosis After Upper Eyelid Blepharoplasty (Single Site Study)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 164 (estimated)
- Sponsor
- Restorix Research Institute, LLLP · Academic / Other
- Sex
- All
- Age
- 40 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to test the effect of Hyperbaric Oxygen Therapy) HBOT (100% oxygen; 2.0 ATA; 90 minute total exposure) and compare against a hyperbaric sham treatment (HBST) (patient's breathing room air; 2.0 ATA; 90 minute exposure) in reducing edema and ecchymosis. HBOT will be applied as a single pre-operative and a single post-operative treatment for patients undergoing eyelid surgery. Briefly, patients will be exposed to HBOT 2-4 hours prior to undergoing surgery, 2-4 hours post-surgery and healing will be assessed at day 3, 10, 21, 30 \& 90 days after surgery. Edema and ecchymosis will be assessed in a time series to determine the extent that HBOT reduces these clinical signs. The primary null hypothesis to test will be that no differences in scores will exist between treatment and control at day 3, 10 \& 21 post-surgery. A secondary null hypothesis to test is the time required to change a score will be no different between the two groups. HBOT=hyperbaric oxygen therapy; HBST=hyperbaric sham treatment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hyperbaric oxygen treatment | Patients that volunteer to participate in this study will be exposed to two treatments (one before surgery; one after surgery) of 100% oxygen at 2.0 atmospheres absolute (ATA) inside mono-place chambers for 90 minutes (at depth). |
| DRUG | Air sham | Patients that volunteer to participate in this study will be exposed to two treatments (one before surgery; one after surgery) of medical grade air (21%oxygen; sham) at 1.2 ATA inside mono-place chambers for 90 minutes. |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2013-11-01
- Completion
- 2013-12-01
- First posted
- 2012-05-24
- Last updated
- 2012-12-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01605110. Inclusion in this directory is not an endorsement.